US

U.S. Physical Therapy, Inc.

USPHHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$781.0M
+16.3% YoY
Net Income
$15.1M
-43.1% YoY
EBITDA
$109.7M
+26.2% YoY
Free Cash Flow
$41.3M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 20 MACD Negative CrossoverHistogram -0.4257, negative momentum
Aug 19 MACD Negative CrossoverHistogram -0.3578, negative momentum
About U.S. Physical Therapy, Inc.

Operating under the Medical Care Facilities umbrella, U.S. Physical Therapy, Inc. is a healthcare company. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. The company carries a $1.18B market cap, placing it firmly in the small-cap category. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.

Where USPH stands vs its 150-day and 200-day moving averages

As of the August 20, 2026 close, USPH finished 6.59% above its 150-day moving average ($74.31) and 5.78% above its 200-day moving average ($74.88). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is USPH overbought or oversold?

At the August 20, 2026 close, USPH's RSI(14) was 47.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.18B
P/E (TTM)466.76
Fwd P/E23.46
EPS$0.17
Beta1.13
52W Change-7.3%
Dividend Yield2.34%
ROE6.5%
Analysis

The company holds $26.3M in cash, though total debt stands at $385.8M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $41.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 6.5%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $553.1M (2022) to $781.0M (2025), reflecting a 41% increase over the period.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for U.S. Physical Therapy, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms